EGEmily C. Gentry

Emily C. Gentry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emily C. Gentry has a total of 393 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A High-Resolution Mass Spectrometry Workflow for Xenobiotic Metabolite Discovery and Toxicity Prioritization: Disperse Orange 61 as a Case Study

    by Kirsten E. Overdahl, Georgia Roberts, Emily C. Gentry, Suramya Waidyanatha, June Dunnick, Alan K. Jarmusch

    Extensive characterization of xenobiotic metabolites remains a major challenge in mass spectrometry-based exposomics, as untargeted high-resolution mass spectrometry (HRMS) can detect extensive chemical diversity but often lacks sufficient structural annotation and prioritization strategies for unknown metabolites. Here, we developed a built-for-purpose HRMS-based workflow combining untargeted metabolomics, in silico metabolite prediction, structural annotation, and toxicity prioritization to characterize xenobiotic biotransformation products using Disperse Orange 61 (DO61) as a case study. Sprague–Dawley rats were exposed to DO61 via oral gavage, and liver, plasma, and urine samples were analyzed by ultra-high performance liquid chromatography (UHPLC) coupled to HRMS in positive and negative ionization modes. Statistically significant features were prioritized and screened against a BioTransformer-generated suspect library containing predicted Phase I, Phase II, reductive, and microbial transformations. HRMS-based annotation, supported by bromine isotope pattern analysis and MS/MS fragmentation, identified putative DO61 metabolites, while SIRIUS-derived molecular formula predictions provided additional confidence through fragmentation-based structural evaluation. The workflow experimentally confirmed reductive azo cleavage as an early DO61 transformation, producing two aromatic amine products, and revealed extensive downstream metabolism of the parent compound and both cleavage products. Computational toxicity prediction further prioritized confirmed and putatively annotated metabolites with potential mutagenic relevance for a future evaluation. This workflow demonstrates how integrating untargeted HRMS with computational approaches can facilitate metabolite discovery, improve structural annotation confidence, and prioritize metabolites for toxicological evaluation, providing a hypothesis discovery strategy for characterizing xenobiotic metabolism and supporting exposure and hazard assessment within the field of exposomics research.

  • Open Access

    Evaluating the Effects of Acquisition and Search Parameters on Repository-Scale MS/MS Matching

    by Allison J. Keys, Emily C. Gentry

    Tandem mass spectrometry (MS/MS) spectral matching is increasingly performed at the repository scale, where tools such as MASST enable a query spectrum to be compared against heterogeneous public data. Unlike analogous genomic-based searches, repository-scale MS/MS matching lacks integrated false discovery rate (FDR) reporting, leaving parameter selection entirely to user discretion. Here, we evaluate how acquisition factors and analysis filters jointly affect MS/MS matching using a curated library of 40 metabolites spanning ten chemical classes. In this study, we find that normalized collision energies from 30 to 50% balance sufficient fragmentation against loss of larger diagnostic ions, producing the most structurally informative spectra and yielding the highest proportion of repository matches. Using a fragmentation-based decoy library, we show that six minimum matching peaks achieve <1% FDR across the entire cosine threshold range tested (0.7–1.0), while fewer matching peaks require increasingly stringent cosine thresholds. These findings provide practical, benchmarking guidance for user-provided acquisition and search parameters in MASST searches.

  • Open Access

    Exploring Acylcarnitine Metabolism Using Reverse Metabolomics

    by Allison J. Keys, Daniel J. Wiener, Sara M. Pacini, Chengze Sun, Lindsay E. Sandusky, Huaiyang Zhong, Emily C. Gentry

    Untargeted mass spectrometry (MS) is a valuable tool for studying human metabolism and identifying small molecule disease biomarkers. However, annotation of chemical structures and validation of findings across numerous cohorts remains challenging. Reverse metabolomics employs a structure-driven approach to overcome these issues by searching spectra of known structures against an entire repository of untargeted LC-MS/MS data to see where metabolites of interest are found. This work uses reverse metabolomics to study acylcarnitine (AC) metabolism in humans and other animals. Here, a library of 76 ACs was chemically synthesized then searched against public metabolomics data to explore where metabolites of interest are detected. From this analysis, it was determined that acylcarnitines are most frequently observed in human and mouse samples, with about 90% of all searched AC structures present in both blood and fecal samples from these species. This work identified positive associations between certain AC structures and disease, indicating their capacity as health biomarkers. Machine learning was applied, determining that AC presence and absence data can accurately predict healthy versus unhealthy individuals with good precision and recall, albeit the models lack disease specificity. Overall, our findings suggest that AC profiles can serve as valuable biomarkers for disease detection throughout the entire lifespan and should be examined for their potential beyond current clinical screening protocols.

  • Open Access

    Potential role of bile acids as a microbiome-derived mechanism in synovitis of knee osteoarthritis synovitis

    by Jessica D. Murillo-Saich, Helena Mannochio-Russo, Marta Sala-Climent, Nathan Argel, Anna Quan, Michal Kalli Hose, Rocio Paz-Gonzalez, Meghana Akkati, Eric Chang, Adnan Cutuk, et al.


  • Open Access

    Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females

    by Megan E Patton, Sherwin Kelekar, Lauren J Taylor, Angela E Dean, Qianying Zuo, Rhishikesh N Thakare, Sung Hwan Lee, Emily C Gentry, Morgan Panitchpakdi, Pieter Dorrestein, et al.

    Hepatocellular carcinoma (HCC), the common liver cancer, exhibits higher incidence in males. Here, we report that mice lacking bile acid (BA) regulators, Farnesoid X Receptor (FXR also termed NR1H4) and Small Heterodimer Partner (SHP also termed NR0B2), recapitulate the sex difference in liver cancer risk. Since few therapeutic options are available, we focused on understanding the intrinsic protection afforded to female livers. Transcriptomic analysis in control and NR1H4 and NR0B2 double knockout livers identified female-specific changes in metabolism, including amino acids, lipids, and steroids. To assess translational relevance, we examined if transcriptomic signatures obtained from this murine HCC model correlate with survival outcomes for HCC patients. Gene signatures unique to the knockout females correspond with low-grade tumors and better survival. Ovariectomy blunts the metabolic changes and promotes liver tumorigenesis in females that, intriguingly, coincides with increased serum bile acid (BA) levels. Despite similar genetics, knockout male mice displayed higher serum BA concentrations, while female knockouts excreted more BAs. Decreasing enterohepatic BA recirculation using cholestyramine, an FDA-approved resin, dramatically reduced the liver cancer burden in male mice. Overall, we reveal that sex-specific BA metabolism leading to lower circulating BA concentration protects female livers from developing cancer. Thus, targeting BA excretion may be a promising therapeutic strategy against HCC.

  • Open Access

    Microbiome-derived bile acid signatures in early life and their association with islet autoimmunity

    by Santosh Lamichhane, Alex M. Dickens, Tanja Buchacher, Tianai Lou, Vincent Charron-Lamoureux, Roosa Kattelus, Pragya Karmacharya, Lucas Pinto da Silva, Matilda Kråkström, Omid Rasool, et al.

    Emerging studies reveal that gut microbes can conjugate diverse amino acids to bile acids, known as microbially conjugated bile acids. However, their regulation and health effects remain unclear. Here, we analyzed early-life microbially conjugated bile acid patterns and their link to islet autoimmunity. We quantified 110 microbial bile acids in 303 stool samples collected longitudinally (3–36 months) from children who developed one or more islet autoantibodies and controls who remained autoantibody-negative. We identified distinct age-dependent trajectories of these bile acid amidates and correlated them with gut microbiome composition. We found that altered levels of ursodeoxycholic and deoxycholic acid conjugates were linked to islet autoimmunity as well as modulated monocyte activation in response to immunostimulatory lipopolysaccharide and Th17/Treg cell balance. These findings suggest that microbially conjugated bile acids influence immune development and type 1 diabetes risk.


  • Open Access

    Leveraging chemical synthesis to discover metabolites from the gut microbiome

    by Allison J. Keys, Nitesh K. Nandwana, Eyas Alnasser, Emily C. Gentry

    The gut microbiome has the biosynthetic potential to make a variety of secondary metabolites or natural products, which serve as molecular messages between cells and organisms. These chemical signals are capable of affecting physiology and behavior in real time, and are, therefore, bioactive and can exhibit medicinal properties including anticancer, antimicrobial, or immunomodulating activities. It is clearly important to identify signaling molecules in the human gut, but elucidating their chemical structures can be challenging since traditional isolation methods are typically not available. The discovery of microbiome‐related metabolites requires multidisciplinary collaboration, where chemical synthesis often plays an essential role. This review highlights examples where synthetic chemistry was used to study novel metabolites produced by the gut microbiota. In the first part, we describe examples where organic synthesis was utilized in traditional contexts, as a last step for validating structures and sourcing material for biological testing. The final section of this review discusses next‐generation applications for chemical synthesis, where integration with metabolomic or genomic analysis simultaneously uncovers both structural and biological information about small molecules from the gut.

  • Top Cited Papers
    Open Access

    microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data

    by Simone Zuffa, Robin Schmid, Anelize Bauermeister, Paulo Wender P. Gomes, Andres M. Caraballo-Rodriguez, Yasin El Abiead, Allegra T. Aron, Emily C. Gentry, Jasmine Zemlin, Michael J. Meehan, et al.

    MicrobeMASST, a taxonomically informed mass spectrometry (MS) search tool, tackles limited microbial metabolite annotation in untargeted metabolomics experiments. Leveraging a curated database of >60,000 microbial monocultures, users can search known and unknown MS/MS spectra and link them to their respective microbial producers via MS/MS fragmentation patterns. Identification of microbe-derived metabolites and relative producers without a priori knowledge will vastly enhance the understanding of microorganisms’ role in ecology and human health.


  • Using Multidimensional Separations to Distinguish Isomeric Amino Acid–Bile Acid Conjugates and Assess Their Presence and Perturbations in Model Systems

    by Allison K. Stewart, Matthew H. Foley, Michael K. Dougherty, Sarah K. McGill, Ajay S. Gulati, Emily C. Gentry, Lee R. Hagey, Pieter C. Dorrestein, Casey M. Theriot, James N. Dodds, et al.

    Bile acids play key roles in nutrient uptake, inflammation, signaling, and microbiome composition. While previous bile acid analyses have primarily focused on profiling 5 canonical primary and secondary bile acids and their glycine and taurine amino acid-bile acid (AA-BA) conjugates, recent studies suggest that many other microbial conjugated bile acids (or MCBAs) exist. MCBAs are produced by the gut microbiota and serve as biomarkers, providing information about early disease onset and gut health. Here we analyzed 8 core bile acids synthetically conjugated with 22 proteinogenic and nonproteogenic amino acids totaling 176 MCBAs. Since many of the conjugates were isomeric and only 42 different m/z values resulted from the 176 MCBAs, a platform coupling liquid chromatography, ion mobility spectrometry, and mass spectrometry (LC-IMS-MS) was used for their separation. Their molecular characteristics were then used to create an in-house extended bile acid library for a combined total of 182 unique compounds. Additionally, ∼250 rare bile acid extracts were also assessed to provide additional resources for bile acid profiling and identification. This library was then applied to healthy mice dosed with antibiotics and humans having fecal microbiota transplantation (FMT) to assess the MCBA presence and changes in the gut before and after each perturbation.


  • Open Access

    Microbiomes and metabolomes of dominant coral reef primary producers illustrate a potential role for immunolipids in marine symbioses

    by Helena Mannochio-Russo, Sean O. I. Swift, Kirsten K. Nakayama, Christopher B. Wall, Emily C. Gentry, Morgan Panitchpakdi, Andrés M. Caraballo-Rodriguez, Allegra T. Aron, Daniel Petras, Kathleen Dorrestein, et al.

    The dominant benthic primary producers in coral reef ecosystems are complex holobionts with diverse microbiomes and metabolomes. In this study, we characterize the tissue metabolomes and microbiomes of corals, macroalgae, and crustose coralline algae via an intensive, replicated synoptic survey of a single coral reef system (Waimea Bay, Oʻahu, Hawaii) and use these results to define associations between microbial taxa and metabolites specific to different hosts. Our results quantify and constrain the degree of host specificity of tissue metabolomes and microbiomes at both phylum and genus level. Both microbiome and metabolomes were distinct between calcifiers (corals and CCA) and erect macroalgae. Moreover, our multi-omics investigations highlight common lipid-based immune response pathways across host organisms. In addition, we observed strong covariation among several specific microbial taxa and metabolite classes, suggesting new metabolic roles of symbiosis to further explore.